Sameera Agro And Infra Limited (NSE:SAIFL)

Oncternal Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	123.77	107.21	100.37	27.42	12.22
Depreciation & Amortization	26.19	0.39	0.45	0.43	0.43
Other Amortization	-	-	-	0	0
Other Operating Activities	0.35	-0.03	-0.03	-0.02	-0
Change in Accounts Receivable	-166.01	-190.2	-175.93	-28.94	-48.74
Change in Inventory	-57.94	-53.01	-1.24	-19.64	-
Change in Accounts Payable	56.71	-204.9	45.61	-12.77	43.05
Change in Other Net Operating Assets	281.63	-173.49	30.9	31.95	45.69
Operating Cash Flow	264.7	-514.03	0.14	-1.56	52.65
Capital Expenditures	-529.09	-111.22	-	-	-0.02
Other Investing Activities	-0.01	-	-	-	-
Investing Cash Flow	-547.81	-111.22	-	-	-0.02
Long-Term Debt Repaid	-9.88	-	-	-	-
Net Debt Issued (Repaid)	-9.88	-	-	-	-
Issuance of Common Stock	-	626.4	-	-	-
Other Financing Activities	293.83	-	-	-	-52.99
Financing Cash Flow	283.96	626.4	-	-	-52.99
Net Cash Flow	0.85	1.15	0.14	-1.56	-0.36
Free Cash Flow	-264.38	-625.25	0.14	-1.56	52.63
Free Cash Flow Margin	-11.18%	-34.33%	0.01%	-0.15%	6.57%
Free Cash Flow Per Share	-4.44	-10.50	0.00	-0.04	1.25
Cash Interest Paid	0.39	-	-	-	-
Cash Income Tax Paid	58.35	38.62	36.16	9.87	4.67
Levered Free Cash Flow	-538.42	-422.22	-14.97	-53.64	51.13
Unlevered Free Cash Flow	-538.12	-422.22	-14.97	-53.56	55.55
Change in Working Capital	114.39	-621.6	-100.65	-29.39	40

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.